aBSTRaCT: The objective of this study was to deter mine the metabolic, stress, and hematology response of beef heifers supplemented with zilpaterol hydrochloride (ZH) when exposed to an endocrine stress challenge. Heifers (n = 20; 556 ± 7 kg BW) were randomized into 2 treatment groups: 1) control (CON), no ZH supplemen tation, and 2) zilpaterol (ZIL), supplemented with ZH at 8.33 mg/kg (DM basis). The ZIL group was supplement ed ZH for 20 d, with a 3d withdrawal period. On d 24, heifers received an intravenous bolus of corticotropin releasing hormone (CRH; 0.3 µg/kg BW) and arginine vasopressin (VP; 1.0 µg/kg BW) to activate the stress axis. Blood samples were collected at 30min intervals for serum and 60min intervals for plasma and whole blood, from −2 to 8 h relative to the challenge at 0 h (1000 h). Samples were analyzed for glucose, insulin, NEFA, blood urea nitrogen (BUN), cortisol, epinephrine, nor epinephrine, and complete blood cell counts. Following the challenge, cattle were harvested over a 3d period. Liver, LM, and biceps femoris (BF) samples were col lected and analyzed for glucose, lactate, and glycolytic potential (GP). There was a treatment (P ≤ 0.001) effect for vaginal temperature (VT), with ZIL having a 0.1°C decrease in VT when compared with CON. A treatment × time effect (P = 0.002) was observed for NEFA. A treat ment effect was observed for BUN; ZIL had decreased BUN concentrations compared with CON (P < 0.001) prior to the challenge; however, no treatment × time effect was observed. There was also a treatment effect for cortisol (P ≤ 0.01) and epinephrine (P = 0.003); ZIL had decreased cortisol and epinephrine during the CRH/ VP challenge when compared with CON. There was a time effect for total white blood cells, lymphocytes, and monocytes; each variable increased (P ≤ 0.01) 2 h post challenge. Additionally, neutrophil counts decreased (P ≤ 0.01) in response to CRH/VP challenge in both treat ment groups. Glucose concentrations within the LM were greater (P = 0.03) in CON when compared with ZIL. Lactate concentrations and GP within the BF were greater in CON (P = 0.05) when compared with ZIL. These data suggest there are some variations observed between treatments in terms of response to the CRH/VP challenge; however, in the environmental conditions of this trial, none of the variations observed suggest that the supplementation of ZH detrimentally alters the ability of cattle to effectively respond to stressful stimuli.
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INTRODUCTION
Zilpaterol hydrochloride (ZH; Zilmax, Merck Animal Health, Summit, NJ) is a β-adrenergic receptor agonist (β-aa) that is approved for use in feedlot cat tle in the United States (Schmidt and Olson, 2007) . In 2013, sporadic reports of lame and slowmoving cattle arriving at abattoirs was attributed to ZH supplemen tation (Thomson et al., 2015) . Zilpaterol hydrochlo ride is a β 2 -AA that functions as a ligand of the β 2 G protein coupled receptors (7 transmembrane domain receptor; Mersmann, 1998) . Ligand binding to the β 2 adrenergic receptor activates adenylate cyclase, thus initiating the synthesis of cyclic adenosine monophos phate (camp), resulting in regulation of the activity of protein kinase A (Mersmann, 1998) .
It is speculated that the binding of ZH to the β 2 adrenergic receptor causes a shift in cell signaling that upregulates genes associated with protein accretion and downregulates genes associated with protein degrada tion and lipogenesis (Mersmann, 1998) . Feeding of β-AA downregulates these receptors, resulting in an uncoupling and a reduction in β-adrenergic receptors available in the plasma membrane of cells (Mills, 2002) . Chronic feeding of ractopamine to swine resulted in up to a 50% decrease in β-adrenergic receptors in adipose tissue (Smith et al., 1994) , thus suggesting a potential interaction between the feeding of β-AA and regulation of the stress axis.
Glucocorticoids are regulators of metabolism, in cluding glucose metabolism, and have been documented for many years (Long et al., 1940) . Changes in blood me tabolites would be expected during the stress response because of energy mobilization that can lead to deple tion of energy stores such as liver glycogen (Moberg and Mench, 2000; Gupta et al., 2005) . This study was designed to determine the effect of β-AA supplementa tion on the metabolic, stress, and hematology response to a dual corticotropinreleasing hormone (CRH) and arginine vasopressin (Vp) challenge in finished heifers.
maTeRIalS aND meTHODS

Experimental Design
All experimental procedures were in compliance with the Guide for the Care and Use of Agricultural Animals in Research and Teaching and approved by the Institutional Animal Care and Use Committee at the University of Nebraska (IACUC #902).
Twenty ovariectomized English-influenced cross bred heifers (initial BW = 556 ± 7 kg) from the University of Nebraska Agricultural Research and Development Center feedlot were utilized for this study. Prior to ini tiation of the study, heifers were acclimated for a 3wk period. During acclimation, heifers were haltered and acclimated to being restrained in a tie stall environment and to human contact. At the end of the 3wk acclima tion period, heifers were assigned randomly to 1 of 2 treatments: 1) control (CON; n = 10), a finishing diet without ZH (Table 1) , and 2) zilpaterol hydrochloride (ZIl; n = 10), the same diet supplemented with ZH at 8.33 mg/kg BW on a DM basis. For delivery of ZH, 5% of the highmoisture corn in the diet was replaced with 4.9853% fine-ground corn and ZH at 0.0147% calculat ed to supply ZH at 8.33 mg/kg on a DM basis. Five per cent of the CON diet was replaced with fine-ground corn to ensure similarity between the 2 diets. All supplements were individually mixed into an individual heifer's daily allotment prior to feeding. Heifers were fed once daily at 0800 for 20 d followed by a 3d withdrawal period of ZH. During the 3d period, the 5% highmoisture corn was returned to both the CON and ZIL diets to replace the 5% ground corn supplement. The trial was designed to follow common industry feeding practices of feed ing ZIL for a 20d period followed by a 3d mandatory withdrawal before heifers were eligible to be shipped to an abattoir. The transportation of cattle results in acti vation of the hypothalamicpituitaryadrenal (Hpa) axis (Falkenberg et al., 2013) ; furthermore, the use of the CRH/VP stress model has resulted in a similar en docrine response (Carroll et al., 2007) when compared with an actual relocation event. Therefore, the CRH/VP challenge on d 24 was utilized as a controlled endocrine stressor to produce an endocrine response that would be similar to that caused by shipping heifers to the abattoir.
Eight days prior to the start of ZH supplementation, heifers were relocated to the University of NebraskaLincoln Agricultural Research and Development Center Nutrition Dairy Barn during the month of December 2013. The Nutrition Barn is a 40stall barn equipped with individual bunks, automatic waters, and dairy mat tresses. Prior to heifers being placed into the barn, tie stalls (first 10 stalls in a row on opposite sides of an al leyway in the barn) were assigned randomly to treatment but blocked by treatment group (2 heifers per block), so that no CON heifers shared water with the ZIL heifers. Heifers were maintained in individual tie stalls (1.34 m wide by 1.84 m long) for the duration of the trial. Pine shavings were added on top of the dairy mattress and replaced when needed. On d −3 (prior to ZH supple mentation, which occurred on d 1), heifers were fitted with indwelling vaginal temperature (VT) monitoring devices (Burdick et al., 2012) that recorded VT at 5min intervals throughout the duration of the study. On d 20 (last d of ZH supplementation), heifers were removed from tie stalls to obtain a BW (for CRH and VP dose calculations) and fitted with indwelling jugular catheters and then returned to their respective tie stalls. For the jugular cannulation procedure, heifers were restrained in a working chute. A small (2 to 3 cm) incision was made in the skin to more easily access the jugular vein. Indwelling jugular catheters, consisting of 30.48 cm of sterile Tygon tubing (AAQ04133; US Plastics, Lima, OH; 1.27 mm i.d. and 2.286 mm o.d.), were inserted into the jugular vein using a 14gauge by 5.08cm thinwalled stainlesssteel biomedical needle (o.d. = 3 mm). The catheter was stabilized using tag cement and 2.08cm wide porous surgical tape around the incision site. The heifer's entire neck reason was wrapped with vet wrap (Vetrap; 3 M Animal Care Products, St. Paul, MN) to ensure stability of the catheterization site. The remaining tubing not inserted into the heifer served as the extension portion of the cannula for collection of blood samples (Burdick Sanchez et al., 2013) . Environmental temper ature and relative humidity data were collected inside the Nutrition Barn utilizing 4 HOBO U23 Pro v2 tem perature/relative humidity data loggers (U23001, Onset, Bourne, MA). Data from all 4 probes were averaged and compiled to provide an overall environmental tempera ture and relative humidity. On d 24, the average environ mental temperature was 13°C ± 1.2°C with an average relative humidity of 52% ± 3.1%. On d 24, the average temperaturehumidity index was 24.8 ± 1.6 within the barn. Prior to d 24, 2 heifers were removed from the trial. One heifer was removed from the trial because of de velopment of a sore underneath the halter on d 13, and the other heifer was removed because of failure of the jugular catheter on d 21; therefore, there were 10 heifers in the CON group and 8 heifers in the ZIL group.
On d 24 at 0600 h, all residual feed was removed from bunks, and daily allotment of feed was not provided until 1900 h (completion of the stress challenge). Starting at 0800 (−2 h) and continuing until 1800 h (8 h), blood samples were collected from each heifer. At 1000 h (im mediately following collection of blood sample), each heifer received an intravenous bolus of bovine CRH (0.3 µg/kg BW) and arginine VP (1.0 µg/kg BW; Carroll et al., 2007) . Following collection of the last blood sam ple (1800 h), catheters were removed, and daily allot ment of feed was delivered. A total of 3 blood samples was collected relative to administration of CRH and VP challenge (1000 h). In 30min intervals during the trial (0800 to 1600 h), one 9mL blood sample was collected into Sarstedt tubes containing no additive (Sarstedt Inc., Newton, NC) for isolation of serum for a total of 17 sam ples. Serum blood samples were allowed to clot for 30 min at room temperature and were then centrifuged at 1,500 × g for 20 min at 4°C. Isolated serum was stored at −80°C until analyzed for glucose, insulin, NEFA, blood urea nitrogen (BUN), and cortisol concentrations. In 60 min intervals during the trial (0800 to 1800 h), one 9mL blood sample was collected in Vacutainers containing EDTA (Fisher Scientific, Pittsburgh, PA) for isolation of plasma. Plasma blood samples were centrifuged imme diately after collection at 1,500 × g for 20 min at 4°C. Isolated plasma was flash frozen in liquid nitrogen and stored at −80°C until analyzed for epinephrine and nor epinephrine concentrations (Burdick et al., 2009) . Also in 60min intervals during the trial (0800 to 1800 h), a 3mL blood sample was collected into Vacutainers con taining EDTA (Fisher Scientific) to determine complete blood cell (CBC) counts using a ProCyte Dx Hematology Analyzer (IDEXX Laboratories, Westbrook, ME).
On d 25, 26, and 27, heifers were harvested at the Loeffel Meat Laboratory located at the University of Nebraska-Lincoln. Heifers were assigned randomly to 1 of the 3 harvest days, and within days, harvest order was alternated on the basis of treatment, resulting in ex tended withdrawal times for heifers harvested on differ ent days (4, 5, and 6 d after ZIL supplementation). After evisceration, samples were obtained from liver, LM di rectly above the 13th rib, and biceps femoris (BF) from the outer center of the muscle. Within 45 min of stun ning, tissue samples were collected and flash frozen in liquid nitrogen and stored at −80°C until analyzed for glycolytic potential, glucose, and lactate concentrations.
Serum Analysis
Serum glucose concentrations were determined in duplicate samples by modification of the enzymatic Autokit Glucose (Wako Diagnostics, Richmond, VA) to fit a 96-well format. Briefly, 300 μL of prepared working solution was added to 2 μL of serum or prepared stan dards in a 96well plate. Plates were incubated at 37°C for 5 min and then read using a plate reader at 505 nm. Concentration of glucose was determined by comparing unknown samples to a standard curve of known glucose concentrations. The minimum detectable concentration was 3.8 mg/dL, and the intra-and interassay coefficients of variation were 7.0% and 9.5%, respectively. Data are presented as the concentration in milligrams per deciliter.
Serum insulin concentrations were determined in duplicate samples by a bovine-specific insulin ELISA according to the manufacturer's instructions (catalog number 80INSBOE01; Alpco Diagnostics, Salem, NH). The minimum detectable concentration was 0.1 ng/ mL, and the intra-and interassay coefficients of varia tion were 11.8% and 17.9%, respectively. Data are pre sented as the concentration in nanograms per milliliter.
Serum concentrations of NEFA were determined in duplicate samples by modification of the enzymatic HR Series NEFAHR (2) assay (Wako Diagnostics, Richmond, VA) to fit a 96-well format. Briefly, 200 μL of the prepared Color Reagent A were added to 5 μL of serum or prepared standards in a 96well plate. Plates were incubated at 37°C for 5 min, and absorbance was read using a spectrophotometer at 505 nm. Next, 100 μL of prepared Color Reagent B were added to all wells on the 96well plate. Plates were incubated for an additional 5 min and read for a second time using a plate reader at 505 nm. Concentrations of NEFA were determined by comparing unknown samples to a stan dard curve of known NEFA concentrations. The mini mum detectable concentration was 0.0014 mmol/L, and the intra-and interassay coefficients of variation were 7.1% and 6.3%, respectively. Data are presented as the concentration in millimoles per liter.
Serum concentrations of BUN were determined in duplicate samples by a colorimetric assay according to the manufacturer's directions (K024H1; Arbor Assays, Ann Arbor, MI) by comparison of unknowns to standard curves generated with known concentrations of urea nitrogen. The minimum detectable BUN concentration was 0.065 mg/dL, and the intra-and intercoefficients of variation were 3.5% and 8.3%, respectively. Data are pre sented as the concentration in milligrams per deciliter.
Serum cortisol concentrations were determined in duplicate samples by enzyme immunoassay according to the manufacturer's instructions (Arbor Assays). Serum concentrations of cortisol were determined by compari son to a standard curve of known cortisol concentrations.
The minimum detectable concentration was 45.4 pg/mL, and intra-and interassay coefficients of variation were 18.6% and 16.0%, respectively. Data are presented as the concentration in nanograms per milliliter.
Epinephrine and Norepinephrine Analysis
Plasma concentrations of epinephrine and norepi nephrine were determined in duplicate samples by en zyme immunoassay according to the manufacturer's directions (17BCTHUE02.1; Alpco Diagnostics) by comparison of unknowns to standard curves generated with known concentrations of epinephrine or norepineph rine (Burdick et al., 2009 ). The minimum detectable con centrations were 10 and 50 pg/mL for epinephrine and norepinephrine, respectively. The intra and interassay co efficients of variation were ≤17.3% and ≤22.3%. Data are presented as the concentration in picograms per milliliter.
Tissue Analysis
Glycolytic potential (Gp) values were calculated using the following formula: GP = 2([glycogen] + [glu cose] + [glucose6phosphate]) + (lactate) (Monin and Sellier, 1985) . Duplicate samples of LM, BF, and liver samples were homogenized in 0.6 N perchloric acid, and glycogen was digested with amyloglucosidase and 20 μL of 5.4 N KOH. Glucose assays were performed with a coupled enzymatic assay kit (hexokinase and glucose 6phosphate dehydrogenase, SigmaAldrich, St. Louis, MO). Lactate content was measured using an enzyme as say including lactate dehydrogenase (Souza et al., 2011) .
Statistical Analysis
Data were analyzed using the MIXED procedure of SAS specific for repeated measures (SAS Inst. Inc., Cary, NC). Treatment, time, and the treatment by time inter action were included as fixed effects, with heifer within treatment included as the experimental unit. If treatment or the treatment by time interaction was significant, data were further analyzed separately in 2 different time pe riods: baseline, the time period prior to administration of CRH and VP (−2 to 0 h), and challenge, the time period following administration of CRH and VP (0 to 8 h). Because of differences in baseline, VT data were analyzed as the change in VT relative to baseline (−2 to 0 h) values, with average baseline VT values included as a covariate. All heifers were challenged at the same time, following collection of the 0 h sample at 1000 h. The authors measured vaginal temperature for several days prior to the challenge; however, for baseline we focused on the 2 h prior to coincide with the baseline sample collection, which began 2 h prior to the challenge.
Additionally, average baseline values were included as a covariate in the analysis of the change in vaginal tem perature. Tissue samples were analyzed with treatment included as a fixed effect and heifer within treatment in cluded as the experimental unit. When main effects were significant, specific treatment comparisons were made using the PDIFF option in SAS, with P ≤ 0.05 considered significant and 0.05 < P ≤ 0.10 considered a tendency. All data are presented as the least squares means ± SEM.
ReSUlTS
VaginalTemperature
There were treatment (P < 0.001) and time (P < 0.01) effects but not a treatment × time interaction (P = 0.96) for VT. Specifically, VT was decreased (P < 0.001) in ZIL compared with CON heifers and varied over time. Because of the treatment effect, with ZIL heifers entering the challenge with decreased VT, the VT data were further analyzed as the change from baseline values (average of values from −2 to 0 h; 0800 to 1000 h), with average base line values included as a covariate in the analysis. The change in VT relative to baseline values was affected by treatment (P ≤ 0.001) and time (P = 0.02), but there was no treatment × time interaction (P = 0.99; Fig. 1 ). Heifers in the CON group had an overall positive change (in crease; P ≤ 0.001) in VT (0.068 ± 0.005°C), whereas ZIL heifers had an overall negative (decrease) change in VT in response to CRH/VP challenge (−0.050°C ± 0.005°C).
Serum Metabolites
There was no treatment effect (P = 0.62) or treat ment × time interaction (P = 0.97) for serum glucose concentrations. There was a time effect (P < 0.001) for glucose concentrations. Regardless of the treatment, glucose concentrations increased (P < 0.001) within 0.5 h of administering the CRH/VP challenge and remained increased until 2 h postchallenge ( Fig. 2A) . There was also no treatment effect (P = 0.82) or treatment × time interaction (P = 0.70) for serum concentrations of insu lin. A time effect (P < 0.001) was also observed for se rum insulin concentrations. Regardless of treatment, in sulin concentrations increased (P < 0.001) within 0.5 h of administering CRH/VP challenge and remained in creased until 2 h postchallenge (Fig. 2B) .
There was a treatment × time interaction (P < 0.001) for serum NEFA concentrations. Prior to challenge, there was no difference (P = 0.27) in serum NEFA concentra tions between CON and ZIL heifers. Concentrations of NEFA were greater in CON heifers compared with ZIL heifers at 4 h (P = 0.04), at 6 h (P = 0.02), and from 7 to 8 h (P < 0.01) following the CRH/VP challenge (Fig. 2C) .
Serum BUN concentrations were affected by treat ment (P < 0.001) and time (P < 0.001; Fig. 2D ), but there was no treatment × time interaction (P = 1.00). In terms of treatment effect, concentrations of BUN were greater (P ≤ 0.001) in CON heifers when compared with ZIL heifers (14.0 ± 0.2 vs. 11.9 ± 0.2 mg/dL, respectively). This dif ference in BUN was observed prior to the CRH/VP chal lenge; baseline concentrations (−2 to 0 h) were greater (P ≤ 0.001) in CON heifers compared with ZIL heifers (13.5 ± 0.3 mg/dL vs. 11.5 ± 0.4 mg/dL, respectively).
Serum cortisol concentrations were affected by treatment (P = 0.002) and time (P < 0.001), but there was no treatment × time interaction (P = 0.09). Overall, cortisol concentrations were greater (P = 0.002) in CON (26.0 ± 0.7 ng/mL) compared with ZIL heifers (23.2 ± 0.07 ng/mL) during the CRH/VP challenge. Specifically, prior to the CRH/VP challenge, baseline (−2 to 0 h) concentrations of cortisol were similar between the 2 treatment groups (P = 0.17; Fig. 3A) . Following admin istration of the CRH/VP challenge, cortisol concentra tions increased (P < 0.001; 0.5 h compared with 0 h) within 0.5 h of the challenge (regardless of treatment) and did not return to near baseline concentrations un til 5.5 h (P = 0.21; 5.5 h compared with 0 h) after the challenge. Although the treatment × time interaction was not significant, there was a tendency (P = 0.09) for cortisol concentrations for ZIL heifers to be decreased from 0.5 to 2 h when compared with CON heifers.
Epinephrine and Norepinephrine Concentrations
Plasma epinephrine concentrations were affected by treatment (P = 0.003) and time (P < 0.001), but there was no treatment × time interaction (P = 0.29; Fig. 3B ). Because of the treatment effect, data were further analyzed within baseline and challenge peri ods. Prior to the CRH/VP challenge, CON heifers had greater (P = 0.005; 33.5 ± 3.0 pg/mL) baseline epi nephrine concentrations (−2 to 0 h) when compared with ZIL heifers (20.4 ± 3.0 pg/mL; Fig. 3) . Following the challenge, there was a treatment (P = 0.03) and time (P = 0.002) effect for epinephrine concentrations but no treatment × time interaction (P = 0.18). After CRH/VP challenge, CON heifers had greater (16.7 ± 1.0 pg/mL) epinephrine concentrations when com pared with ZIL heifers (13.4 ± 1.0 pg/mL; Fig. 3B ).
There was only a time effect (P ≤ 0.001) for plasma norepinephrine concentrations (treatment: P = 0.94; treatment × time: P = 0.44; Fig. 3C ). Norepinephrine concentrations decreased (P ≤ 0.001) 1 h following administration of CRH/VP. Concentrations remained decreased for the duration of the study (P ≤ 0.001, 8 h compared with 0 h; Fig. 3C ) for CON and ZIL heifers.
Complete Blood Cell Counts
There were no main effect differences in total red blood cells (P = 0.82), hemoglobin (P = 0.14), or plate lets (P = 0.70; Table 2 ) between CON and ZIL heifers. There was a tendency (P ≥ 0.06) for both total red blood cells and hemoglobin to change over time regardless of treatment. There was a time difference (P ≤ 0.001) for platelets, with platelet concentrations increasing relative to the CRH/VP challenge in both CON and ZIL heifers. There was a treatment × time interaction (P = 0.03) for hematocrit. Therefore, hematocrit concentrations were further analyzed as baseline and postchallenge. There was a tendency (P = 0.06) for a treatment effect and a dif ference (P = 0.05) over time during the baseline period between treatments for hematocrit. Therefore, change from baseline was calculated and analyzed as a percent change between treatments. There was no difference for treatment (P = 0.85; Table 2) or treatment × time (P = 0.80) for percent change in hematocrit. However, there was a time difference (P = 0.04) for percent change in hematocrit such that hematocrit concentrations de creased following administration of CRH/VP.
Total white blood cells (Fig. 4A) , lymphocytes (Fig. 4B) , and neutrophils (Fig. 4C) were not affected by treatment (P ≥ 0.41) or a treatment × time interaction (P ≥ 0.60); however, these variables were affected by time (P < 0.001). White blood cells and lymphocytes increased (P < 0.001) 2 h following administration of CRH/VP and remained increased for the duration of the study (P < 0.001, 8 h compared with 0 h). In contrast, neutrophils de creased (P < 0.001) 3 h following administration of CRH/ VP and remained decreased for the duration of the study (P < 0.001, 8 h compared with 0 h). There was a treat ment × time (P = 0.04) interaction for monocytes (Fig.  4D) . However, no time points were different between treatment groups during the trial. The treatment × time interaction can primarily be attributed to a greater fluctua tion of monocyte concentrations within the CON heifers. There was a treatment effect (P = 0.04) for eosinophils; eosinophils were greater for CON (0.13 10 3 /μL; Table 2 ) when compared with ZIL heifers (0.007 103/μL). There was a treatment × time (P = 0.04) interaction for basophil concentrations. At 8 h after CRH/VP challenge, basophil concentrations were greater for ZIL heifers when com pared with CON heifers (0.002 × 103 vs. 0/μL, respec tively; Fig. 4E ) during the CRH/VP challenge.
Tissue Samples
There were no differences (P = 0.49) in concentra tions of glucose or lactate and no difference in GP for the liver samples between the CON and ZIL heifers (Table 3) . Glucose concentrations within the LM were greater (P = 0.03) in CON heifers (47.95 ± 12.01 µg/ mol) compared with ZIL heifers (35.84 ± 10.74 µg/ mol; Fig. 2A ). Supplementation of ZH did not affect lactate concentrations (P = 0.39) or total GP (P = 0.11) for LM samples (Table 3) . Glucose concentrations in the BF tissue samples were not affected (P = 0.22) by ZH supplementation (Table 3) . Lactate concentrations in BF tissue samples were greater (P = 0.05) in CON (71.75 ± 6.90 µg/mol) heifers when compared with ZIL heifers (64.47 ± 7.79 µg/mol; Table 3 ). Furthermore, there was a treatment effect for GP in BF samples (P = 0.05; Table 3), with CON heifers having greater con centrations (140.47 ± 23.60 µg/mol) compared with ZHsupplemented heifers (120.05 ± 17.55 µg/mol).
DISCUSSION
Data from the current study indicate that activation of the HPA axis will increase both stress and metabol ic variables. Activation of the HPA axis is a cascading response, regulated by the magnitude of the stressor Control represents heifers that were not fed ZH, whereas ZIL represents heifers fed ZH for 20 d followed by a 3d withdrawal. (Tsigos and Chrousos, 2002 ). An acute response may re sult in brief downregulation of systems not necessary for survival, such as digestion and reproduction, and stimu late catabolism of energy stores and body tissues to be used for energy (Sapolsky et al., 2000) . Although there are data to suggest the initiation of a stress response dur ing relocation events (Falkenberg et al., 2013) , there are few or no data available to describe how this event is al tered because of supplementation of β-AA.
Studies in cattle using other β-AA (i.e., clenbuterol) have observed differences in glucose, lipid, and protein metabolism (Eisemann et al., 1988 ), yet these metabo lites were measured early in the supplementation process rather than following withdrawal as in the current study. When glucose and insulin were measured on d 13 of ci materol supplementation in steers, there were no differ ences in glucose or insulin concentrations compared with control steers (Chikhou et al., 1991) . Additionally, results from a study in finishing steers revealed decreased glu cose concentrations after 21 d of supplementation with ZH (Van Bibber et al., 2010) . The observed difference in glucose concentrations reported by Van Bibber et al. (2010) differs from the current study in which no treat ment differences in circulating concentrations of glucose were observed in response to ZH supplementation in cattle. The differences observed between the study by Van Bibber et al. (2010) and the current study could be due to sample frequency and the collection of samples following a 3d withdrawal in the current study, which the previous studies did not include. In the current study, samples were obtained through indwelling jugular cathe ters in 30min increments, whereas in Van Bibber et al.'s (2010) study, blood samples were collected only once daily by processing cattle through a processing facility. Furthermore, the current study was conducted within an indoor environment where less maintenance energy re quirements would be expected (Hoffman and Self, 1970) . Comparison of different compounds and species should be conducted with great caution because of the diversity of β-adrenergic receptors and receptor tissue distribution differences in livestock species (Mersmann, 2002) .
There are limited reported data regarding the effect of β-AA on body temperature in any species, including cattle. The feeding of ZH has been reported to decrease ruminal temperature when compared with control steers not fed ZH (Boyd et al., 2015) . As reported by Boyd et al. (2015) , the decreased body temperature may be attributed to increased respiration rates, allowing ZH supplemented steers the ability to dissipate excess body heat. In this study, authors attributed decreased body temperature to increased respiration rates, which has been published by others (Boyd et al., 2015) . Another bi ological response typically observed following stimula tion of the β-adrenergic receptors is vasodilation of inte rior tissues (e.g., skeletal muscle, heart, lungs, liver, and gastrointestinal tract; Dawes et al., 1997 ). An increase in vasodilation would support the observed decrease in body temperature, as this would allow dissipation of heat from the body surface at a faster rate compared with CON heifers. However, a decline in vasodilation with continued treatment of β-AA would be expected be cause of a possible downregulation of the β-adrenergic receptors (Smith et al., 1994) . Understanding blood flow changes as a result of β-agonists supplementation, par ticularly ZH, would help justify differences observed in body temperature and also nutrient delivery and blood cell population changes. In the current study, VT sup ports decreased body temperature with ZH feeding that could potentially benefit the animal during stress, allow ing the animal to dissipate excess body heat.
Following administration of the CRH/VP challenge, an increase in VT was observed in both treatments within 25 min. Although VT remained increased in CON heif ers, a return to baseline and subbaseline values was ob served in ZIL heifers. The temporal VT response to the CRH/VP challenge in the current study has similarities to the response observed in weaned Brahman calves chal lenged with CRH; in that study the authors reported fluc tuations in rectal temperature in the 8h period following CRH administration (Hulbert et al., 2013) .
The adrenergic receptors are the receptors that cat echolamines (i.e., epinephrine and norepinephrine) bind to initiate a response and are distributed throughout the body. There are 2 major types of adrenergic receptors, the α-and β-adrenergic receptors, both of which have several subtypes and are all membranebound recep tors (Mersmann, 1998) . Although β-adrenergic receptors are located in most mammalian cells, the β 2 adrenergic receptors are the primary receptors located in both adi pose and skeletal muscle (Mersmann, 1998) . Specifically, ZH is considered a β 2 AA (Hilton et al., 2009) . Initial feeding of β-AA has been reported to increase NEFA concentrations (Mersmann, 1998) . During the initial stages of feeding, β-AA exhibit more lipolytic effects, a biological effect that may eventually be downregulated during extended feedings and as fat content decreases. In a prior study, concentrations of NEFA measured weekly during ZH supplementation in finishing steers showed no difference (Van Bibber et al., 2010) , thus supporting data from the current study as baseline NEFA concentra tions did not differ between treatments groups.
The decrease in NEFA concentrations in response to the CRH/VP challenge in the ZHsupplemented heifers is not surprising considering the increase in lean tissue growth and the decrease in lipogenesis that has been observed in β-AA-fed cattle (Sillence, 2004) . Feeding β-AA leads to decreased lipid deposition and thus decreased NEFA concentrations when stimulated by a catabolic agent such as cortisol. Studies reported in the literature have demonstrated that β-AA have antilipogenic effects (Dunshea, 1993; Sillence, 2004) , data that also support the results in the current study.
The major growth-promoting effects of β-AA are primarily observed in skeletal muscle (Sillence, 2004) , which results in the catabolism of protein from other tis sues to build muscle, although this is only critical when cattle are provided inadequate nutrition (Sillence, 2004) . Furthermore, β-AA activate β-receptors in muscle and adipose tissue, resulting in decreased lipogenesis and increased lipolysis and protein accretion (Mersmann, 1998) . Therefore, the decreased BUN concentrations in ZHsupplemented heifers is likely due to increased anab olism of protein in skeletal muscle and decreased ca tabolism of protein in other tissues as these heifers were provided adequate nutrition to support additional lean tissue accretion during the study (Bell et al., 1998) . The decrease in BUN observed in the current study is sup ported by work with other β-AA in which the authors ob served similar decreases in BUN concentrations in cattle supplemented with cimaterol (Chikhou et al., 1991) . The increase in BUN concentrations after CRH/VP challenge in both treatment groups is in agreement with the in creased concentrations of NEFA observed postchallenge and suggests a greater energy demand during this period than was supplied by glucose alone. Decreased BUN concentrations in ZHsupplemented cattle observed in the current study are supported by work in finishing steers in which the authors reported decreased BUN concentrations after 20 and 21 d of ZH supplementation (Parr et al., 2010; Van Bibber et al., 2010) .
Baseline cortisol concentrations were not different between treatments in the current study. This is in agree ment with a study utilizing a cimaterol treatment in steers, where no difference in cortisol concentrations were ob served 1 and 13 d following initiation of oral dosing (Chikhou et al., 1991) . The temporal pattern associated with an acute increase in circulating concentrations of cor tisol followed by a subsequent decline in the current study is similar to that observed in Brahman calves in response to a CRH challenge (Hulbert et al., 2013) , although the magnitude of the cortisol response was greater in the cur rent study. Control heifers produced a greater cortisol response to the CRH/VP challenge compared with ZIL heifers, thus suggesting a possible downregulation of as pects associated with HPA axis regulation. As mentioned above, there is cross talk between the sympathomedul lary system and the HPA axis. Thus, the observed cortisol response suggests that supplementation of ZH not only influenced the sympathomedullary system but may have downregulated portions of the HPA axis either directly or through actions on the sympathomedullary system. Differences observed in epinephrine concentra tions but not norepinephrine concentrations would theoretically be expected when feeding ZH. Naturally occurring physiological β-adrenergic agonists consist of norepinephrine, a neurotransmitter, and epinephrine, an adrenal medullary hormone (Mersmann, 1998) . Both epinephrine and norepinephrine are capable of binding to the α 1 -, α 2 -, β 1 -, and β 2 adrenergic recep tors (Robinson et al., 1989) ; however, β 2 adrengeric receptors have a greater affinity for epinephrine com pared with norepinephrine. Therefore, the lack of downregulation of the norepinephrine response may be due to the difference in receptor affinity. With ZH being classified as a β 2 AA, it should not affect the regulation of norepinephrine via actions on the α 1 -, α 2 , and β 1 adrengeric receptors. Adenylate cyclase in the erythrocytes of frogs has been used to demonstrate a loss of β-adrenergic receptor binding sites in response to catecholamineinduced sensitivity. When injected with norepinephrine or isoproterenol (β 1 AA), cyclic adenosine monophosphate generated from frog eryth rocyte membranes decreased compared with controls (Mukherjee et al., 1975) . The authors concluded that the decrease in catecholamine responsiveness was due to a reduction in β-adrenergic receptors or a conformational change resulting in inactive receptors (Mukherjee et al., 1975 ). In the current study, decreased concentrations of epinephrine in ZIL heifers would further support a downregulation of the sympathomedullary axis via ac tion on the β 2 adrengeric receptors as discussed above. Few studies have determined the effect of CRH or a combined CRH/VP challenge on immune cell popu lations, particularly in cattle; however, increased gluco corticoids result in an increase of neutrophils (Burton et al., 2005) . Immune cell populations are sensitive to CRH, as well as the intermediate stress hormone, ACTH, and cortisol. Hulbert et al. (2013) observed a decrease in total leukocytes at 1 h following a CRH challenge in Brahman calves. This is in contrast to the current study, in which an increase in total WBCs was observed 2 h following CRH/VP administration regardless of treatment. Many factors may contribute to these opposing observations, including age of the cattle, breed of the cattle, and/or the combination of a CRH challenge with VP given simul taneously vs. a solitary CRH challenge. Although there are limited studies utilizing CRH, the CRH/VP challenge in this study was utilized to mimic an acute stressor. In mice exposed to acute restraint stress, an increase in nat ural killer cells, a subset of lymphocytes, was observed (Bauer et al., 2001) . Furthermore, the use of cyanoketone, an androstanol, in restraintstressed rats resulted in less cortisol production during the time of stress (Dhabhar et al., 1996) . The blocking of cortisol production with cya noketone also significantly reduced the stress-induced decrease in leukocytes that has been reported in rats un der acute stress (Dhabhar et al., 1996) .
The decrease in circulating neutrophils following CRH/VP challenge is indicative of movement of neu trophils out of the blood and into the tissues in prepara tion for immune activation (e.g., wounding). In contrast, the increase in circulating total WBC and lymphocytes suggests a mobilization of these cells (Dhabhar et al., 2012) . This redistribution of immune cells suggests an activation of the immune response, as several factors, including chemoattractants, cell adhesion molecules, and cytokines, are needed for this process to occur (Bauer et al., 2001) . Changes in expression of cell ad hesion molecules, stimulated by stress hormones, may be responsible for the changes observed in immune cell populations not only in response to CRH/VP challenge but in response to ZH supplementation.
Glycolytic potential is a measurement of glucose, lactate, glycogen, and glucose6phosphotase that is present in muscle that ultimately can be converted to lactic acid. This index can be used as a measurement of the capacity for postmortem glycolysis in mus cle, resulting in a decrease of muscle pH in the con version of muscle to meat (Monin and Sellier, 1985) . Glycolytic potential has been evaluated as a potential measurement of meat quality in beef and pork (Wulf et al., 2002; Hamilton et al., 2003) . In cattle, GP has been reported to have a curvilinear response with ultimate LM pH after harvest. Muscle samples with a GP less than 100 µmol/g are associated with a greater postmor tem pH that results in decreased lactate production and can cause dark, firm, and dry beef (Wulf et al., 2002 ). In the current study, GP in the LM was not different in CON and ZHsupplemented heifers. In the BF, ZH supplemented heifers did have a decreased GP; howev er, this was associated with less available lactate, result ing in a decreased calculated GP, and was greater than the 100 µmol/g threshold that has been suggested for optimal pH postmortem. In previous ZH studies, Hilton et al. (2009) reported ZH supplementation increased beef color, resulting in a brighter cherry red favorable beef color during a 5d shelf life study. Furthermore, Montgomery et al. (2009) reported ZH supplementa tion increased LM cherry red color and resulted in a decrease of darkcolored LM when compared with con trol carcasses. The increase in bright cherry red color was attributed to an increase in myoglobin content that resulted in a favorable improvement in muscle color . In liver samples, there was no difference in glucose, lactate, or GP observed in CON and ZHsupplemented heifers. In the rat model, it has been reported that protein kinase activity on gly cogen synthase in skeletal muscle predominantly takes place in the liver (Imazu et al., 1984) . Furthermore, the lack of differences in glucose and GP between treat ment groups of liver samples would further support the fact that no differences in serum glucose were ob served in the current study. If blood glucose concentra tions decreased, glucagon would be released from the α-cells of the pancreas to raise blood glucose concen trations (Navarro et al., 1999) . These data suggest that ZHsupplemented heifers do not have decreased avail able energy stores in muscle or liver samples that could cause muscle fatigue from lack of an energy source.
Also, these data demonstrate that a simulated stress induced by administration of CRH/VP in beef cattle elicits shifts in immune cell populations and metabolic variables, and stress hormones, metabolic variables, and immune cell responses are altered in beef heifers supplemented with ZH when cattle are ex posed to a simulated stress challenge. However, within the environment of this study, supplementation of ZH did not appear to hinder a finishing heifer's ability to mount a stress, immune, or metabolic response during a neurohormoneinduced stimulated stress challenge.
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